The metabolism of synthetic leukotriene B4 in synovial fluid and whole human blood.
The metabolism in vitro of synthetic leukotriene B4 (LTB4) in synovial fluid from rheumatoid arthritis and osteoarthritis patients and in whole blood from these same patient groups and from normal volunteers has been studied. A linear relationship existed between a plot of the time of incubation of samples with LTB4 and the percentage of the initial concentration of LTB4 at each time point. The slope of this line, the rate constant for metabolism, has been used to compare different samples. LTB4 was metabolised more rapidly in the synovial fluid of rheumatoid arthritis patients than osteoarthritis patients. Furthermore, LTB4 was metabolised more rapidly in the blood of rheumatoid arthritis patients than either osteoarthritis patients or normal volunteers. These differences in metabolism correlate with the polymorphonuclear leukocyte (PMN) and albumin content of samples. It is suggested that binding of LTB4 to albumin in vivo will in part determine the available concentration of LTB4 in inflammatory lesions.
Forrest
M J
MJ
Department of Rheumatology, Royal North Shore Hospital of Sydney, New South Wales, Australia.
Burton
D
D
Brooks
P M
PM
D001172:Arthritis, Rheumatoid / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D007975:Leukotriene B4 / Q000097:blood / Q000378:metabolism*; D009504:Neutrophils / Q000378:metabolism*; D010003:Osteoarthritis / Q000378:metabolism*; D012016:Reference Values; D013582:Synovial Fluid / Q000378:metabolism*
D007975:Leukotriene B4